- Diagnostic Différentiel
Drug Information for CefTRIaxONE for injection and Dextrose Injection (B. Braun Medical Inc.): ANIMAL PHARMACOLOGY
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- ANIMAL PHARMACOLOGY
- HOW SUPPLIED
- Liens externes liés à CefTRIaxONE for injection and Dextrose Injection (B. Braun Medical Inc.)
Concretions consisting of the precipitated calcium salt of ceftriaxone have been found in the gallbladder bile of dogs and baboons treated with ceftriaxone.
These appeared as a gritty sediment in dogs that received 100 mg/kg/day for 4 weeks. A similar phenomenon has been observed in baboons but only after a protracted dosing period (6 months) at higher dose levels (335 mg/kg/day or more). The likelihood of this occurrence in humans is considered to be low, since ceftriaxone has a greater plasma half-life in humans, the calcium salt of ceftriaxone is more soluble in human gallbladder bile and the calcium content of human gallbladder bile is relatively low.
- Drug Information Provided by National Library of Medicine (NLM).